Clinicopathological risk factors of Stage II colon cancer: results of a prospective study - Wikidata - wikimedia - TriplyDB

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

http://www.wikidata.org/entity/Q58053589

about

Extramural extension as indicator for postoperative adjuvant chemotherapy in Stage IIA (pT3N0) colon cancer.The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.A scoring system based on artificial neural network for predicting 10-year survival in stage II A colon cancer patients after radical surgery.Lymphatic drainage of the liver and its implications in the management of colorectal cancer liver metastases.Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry.Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.Significance of R1 resection margin in colon cancer resections in the modern era.Individualized prediction of perineural invasion in colorectal cancer: development and validation of a radiomics prediction model.Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.UEG Week 2015 Poster Presentations Intrahepatic lymphatic invasion but not vascular invasion is a major prognostic factor after resection of colorectal cancer liver metastases Unsupervised analyses reveal molecular subtypes associated to prognosis and response to therapy in colorectal cancer

P2860

Q34441890-CBD75DE6-7DA4-49A2-919C-8374C370E666 Q34660196-33EAC60E-87F0-4A9E-A5F5-432BF80B8E9B Q35067307-2505BBF5-11E9-4FB2-99E0-F24726E0BA18 Q37225718-B6189E38-9120-49D0-8BA0-320A49E47048 Q38244336-DDBAA8C1-93D2-4BE3-86C5-48A2FDB2D1F1 Q39299445-30A0F420-14CF-44F1-9FB9-939C7C8F6F58 Q40888514-893EACE8-0513-4EAA-828A-62D160379F79 Q41161328-2DADEAD5-764B-4D76-90DE-5016C16097B8 Q52653169-A3D0C4FE-C7DA-481B-ABD2-8B9C670377CF Q53188064-918FA5FA-8508-4FB0-A493-DE90E4EAA396 Q56934656-944AB659-A080-4955-8281-F9479968A3A2 Q57151076-2B627030-42C0-45E6-9F05-597B5ACB6A94 Q58053541-FFD938E6-4EEF-4345-A25F-5E1A808FA275

P2860

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

http://www.wikidata.org/entity/Q58053589

description

scientific article published on 01 April 2013

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2013

@uk

name

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@en

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@nl

type

label

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@en

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@nl

prefLabel

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@en

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@nl

P1433

Q58053589-668CA9F6-41E8-4C9F-A75B-F48D89AEB6CC

P1476

Q58053589-F0108E9B-C01C-4B6A-9A81-283965F0ECEE

P2093

Q58053589-38F75F5F-B553-4065-A164-EAB8E51262A1

Q58053589-5646DAD9-1F90-46F9-963E-6FF54F161B0B

Q58053589-7D31122F-606E-4509-8A7E-47CB39D1FCA4

Q58053589-8F65EFA9-EC94-4DF7-823B-7D6E74759B03

Q58053589-988E6F68-38CE-4B8F-9E69-D2F488A81B94

Q58053589-9F1ED321-5B5D-409F-B18F-DA1ACBAAC836

Q58053589-B9809A0C-DC17-412F-8F53-5EB6BE9319BC

Q58053589-BD9F0AC4-F6C5-4FC5-AC60-D757B20C3B5D

Q58053589-CC671CBA-A1F6-4DCC-8EFB-58ACD2ACB65F

Q58053589-CFDB0981-7F35-42CF-9163-FC52B1B68E04

P2860

Q58053589-09301C79-737F-4454-8961-F4B5E004083D

Q58053589-099EC069-82F1-4034-8E80-A54614E47A1B

Q58053589-3B975E59-4751-4CA8-B719-EDD4C19CDBC8

Q58053589-4793F2D5-D55A-4704-8284-FF7B6F950EF3

Q58053589-48386324-DE79-4C4B-BECC-E0EE50A303DC

Q58053589-5D289815-3E6F-4437-B30E-AF74A5C896CB

Q58053589-6DE3B74F-E9D3-4FE0-8BB4-B18133A884B4

Q58053589-78DD8C0C-7552-4F9E-9215-7729E8872B97

Q58053589-86FBC4AB-8C8F-4FE1-B4E4-DF4DE03F9C76

Q58053589-91632D62-5BB6-404C-B399-3F43A1450866

P304

Q58053589-15E08464-B266-42A4-BF3F-047DAFF33975

P31

Q58053589-CDDCA60B-53A1-41E3-A4E3-34CB4D1E15AD

P356

Q58053589-790DB9B9-B6AF-4672-8F7D-2C6797972724

P433

Q58053589-9F9A5309-50FB-4DD8-A6E9-21DC7E149880

P478

Q58053589-C9F96A4B-1D06-4F30-B1D4-1F046728C8E9

P50

Q58053589-5D6E2814-657C-49DF-8E0A-9BE62AB3B00E

Q58053589-7718E927-8817-485E-B22A-13A1231B70F4

Q58053589-8129B7DC-6DA4-4AEC-A56F-6D2D5564FFC0

P577

Q58053589-3194F714-332E-412E-BF9E-BD00194AEF93

P698

Q58053589-FBE93BE8-AB4B-495E-8F06-7DBFBFF2103E

P356

P1433

Colorectal Disease

P1476

Clinicopathological risk factors of Stage II colon cancer: results of a prospective study

@en

P2093

A López-Doriga

http://www.w3.org/2001/XMLSchema#string

B Laquente

http://www.w3.org/2001/XMLSchema#string

C Santos

http://www.w3.org/2001/XMLSchema#string

E Kreisler

http://www.w3.org/2001/XMLSchema#string

G Soler

http://www.w3.org/2001/XMLSchema#string

J Mateo

http://www.w3.org/2001/XMLSchema#string

J R Germà

http://www.w3.org/2001/XMLSchema#string

M Martínez Villacampa

http://www.w3.org/2001/XMLSchema#string

M Navarro

http://www.w3.org/2001/XMLSchema#string

R Frago

http://www.w3.org/2001/XMLSchema#string

P2860

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Estimates of cancer incidence and mortality in Europe in 2008.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population

A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer.

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.

The impact of spontaneous tumour perforation on outcome following colon cancer surgery.

P304

414-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CODI.12028

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Elisabet Guinó

Maria J Paúles

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22974322

http://www.w3.org/2001/XMLSchema#string